List of Devices Companies in Washington - 37

Founded by Dr. Elizabeth Ruzzo, adyn is helping people find birth control without side effects based on a person's genetic risk and hormone profile. Despite the 47M birth control users in the US, virtually no studies examine the biological factors that explain why individuals respond differently to a given contraceptive method. Launched in May 2022, The Birth Control Test is the first test designed to prevent birth control side effects. While we are improving the birth control experience, we are also committed to closing the gender health gap. By partnering with individuals, adyn leverages personal preference, medical history, and biological data to proactively help every (unique) body select the most desirable birth control option – with the least dangerous side effects. Our vision is to be earth's most inclusive and patient-centric personalized medicine company. When a person uses The Birth Control Test, they can opt in as an anonymous research participant to help close these research gaps. This means you can simultaneously find the right birth control for your body, while helping others do the same.

Aseptica is a medical device development company focused on EDTA related products.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines in the areas of oncology and infectious diseases. The company’s lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-301, a proprietary drug candidate for nasal administration in patients diagnosed with COVID-19; AT-H201, a drug candidate to improve lung function in COVID-19 patients; and immunotherapy/chimeric antigen receptor therapy programs for the treatment of breast cancer. Atossa Therapeutics, Inc. has a research agreement with Dana-Farber Cancer Institute, Inc. to support research of cytokine-coated nanoparticles for the potential treatment of breast cancer. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care.

Cadence Biomedical, a commercial-stage medical device company headquartered in Seattle, Washington, is committed to working with healthcare professionals, patients and caregivers to advance neurorehabilitation. The company's primary commercial product, Kickstart®, is a neurorehabilitation device designed to accelerate a recovery to walking in stroke, multiple sclerosis, spinal cord injury patients and in individuals with other progressive neurological conditions. Kickstart is available for use in physical therapy during the initial recovery process and as a prescribed device for post-discharge use in the community and home settings. For more detail, please see www.cadencebiomedical.com.

Cardiac Insight, Inc. is a privately held medical device company based in Seattle, Washington, renowned for its Cardea SOLO ECG system. With FDA clearance since 2017, this tool provides comprehensive cardiac evaluations, comfortably worn over seven days. Dr. Dave Hadley and Dr. Vic Frolicher, creators of the Cardea 20/20 ECG, introduced a proprietary handheld 12-lead ECG device that enhances electrocardiogram reliability for detecting cardiovascular issues in young athletes, transforming athletic heart care. The Cardea 20/20 ECG incorporates breakthrough interpretive algorithms and international criteria, enabling swift identification of complex cardiac abnormalities leading to Sudden Cardiac Arrest (SCA). In 2021, Cardiac Insight joined forces with global electronic components leader Dreamtech, solidifying its position as a leading innovator in cardiac healthcare diagnostics, poised for exponential growth.

Medical device company innovating a patent-pending device to provide safety with indwelling urinary catheters.

Founded in 2015, Cerevast Medical, Inc. is a clinical-stage medical device company based in Bothell, Washington, USA. Leveraging our core expertise in the fields of ultrasound and microsphere technologies, we are committed to developing novel, first-in-class therapeutic solutions to restore health and improve the quality of life for patients that suffer from major diseases.

CurvaFix is developing implantable products to improve fracture repair in curved bones. The company is focusing on Fragility Fractures of the Pelvis (FFP) and high-impact pelvic fractures. The CurvaFix® IM Implant is the only intramedullary device capable of following the natural bone shape and filling the space within curved bones such as the pelvis.

Downstream Therapeutics is a biotechnology company that focuses on developing a combination drug-device to reduce cell injury after restoration of blood flow.

Engineering and Design of Implantable Medical Devices We are the industry leader in Engineering and Design of implantable medical devices and have helped many companies through the product development and regulatory approval process. ECHOBIO LLC has over 18 years of experience with medical devices including self-expanding and balloon expandable stents, stent grafts, heart valves and others, as well as a strong background in implantable materials (metals, polymers, ceramics and biomaterials). This experience provides a solid foundation for using FEA and improves our simulation of devices and surgical procedures. We participate on international standards committees and pioneer innovative materials research to develop better engineering methods for making safe and reliable implantable medical devices. Our goal is to put our engineering and medical product expertise to work for customers and partners, helping them to move quickly and confidently to market with safe and effective products. From concept through design, development and regulatory approval, ECHOBIO LLC can help you create better products.

Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. For more information, visit www.bostonscientific.com and connect with us on X, Instagram, and Facebook. At Boston Scientific, you will find purpose, a place to grow and opportunities to cultivate your passions. To search and apply for open positions, visit https://bostonscientific.eightfold.ai/careers. You may also review our social media guidelines at http://www.bostonscientific.com/social.

Founded in 2002 and headquartered in Seattle, WA, EMulate Therapeutics is a clinical-stage therapeutic device company. EMulate Therapeutics has invented and patented a groundbreaking technology that utilizes precisely targeted, ultra-low radio frequency energy (ulRFE®) to specifically regulate signaling and metabolic pathways on the molecular and genetic levels – without chemicals, radiation or drugs – delivered via a simple-to-use non-invasive device called EMulate Therapeutics Voyager. The company's goal is to transform disease treatment on a global scale with ulRFE®. The proprietary technology has the potential to be applied to a wide range of conditions as well as veterinary medicine and non-medical applications. EMulate Therapeutics' initial focus is on the treatment of patients with brain cancer who are not well served by conventional standard of care therapies, which often result in poor outcomes and devastating side effects. Additional pre-clinical work is focused on exploring new applications in oncology and pain treatment.

Fluke Biomedical manufactures biomedical test and simulation products, including electrical safety testers, patient simulators & performance analyzer.

Healionics is addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure. Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of occlusion and infection suffered by current devices. We also have an exciting product pipeline based on our platform STAR® biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices: scarring and infection. The company is currently conducting human studies of STARgraft and has 36 patents issued or pending.

Inmedixfocuses on autonomic nervous system (ANS) control of stress responses within the brain. In the setting of an autoimmune disease, ANS stress can significantly intensify an autoimmune disease. Inmedixcall’sit Immuno-autonomics. Theyseek to understand and block this process to allow current autoimmune disease therapies to work much better.

At Kestra, we stand for patients at-risk and the people who care for them. Together we work to protect, support, and empower them with wearable technologies, tools, and better answers as they navigate life's most challenging medical events. Cardiovascular disease is the number one cause of death globally. We're taking a fresh approach to cardiac monitoring and delivery of definitive therapy with wearable products and applications. We aim to make the entire recovery process easier for patients by bringing comfort and assurance to them—along with advanced clinical insights and tools to their medical care teams. Kestra is a privately held, Bain Capital portfolio company, headquartered in Kirkland, Washington USA. Visit us at www.kestramedical.com

KitoTech Medical is a Seattle-based medical device company that has developed microMend PRO, a unique wound closure device. microMend PRO is a new wound closure device that is as effective as sutures and as fast and easy to apply as a bandage. It delivers superior clinical results and improved patient experience while reducing procedure costs. microMend PRO can close wounds up to 50 cm in length and is effective in closing all types of lacerations including those with jagged edges. Our products are used by medical personnel in emergency medicine, dermatology, surgeons, and more. Request a quote for your clinic today!

Know Labs is transforming non-invasive medical diagnostics. The proprietary technology platform uses radiofrequency (RF) dielectric spectroscopy and can be integrated into a variety of wearable, mobile, or bench-top form factors. The first application is a non-invasive continuous blood glucose monitoring device that will provide the user with real-time information on their blood glucose levels, assisting billions of people with diabetes and prediabetes to manage this medical condition. Know Labs is a public company whose shares trade under the stock symbol KNW (NYSE American).

Magnolia Medical Technologies is on a Mission to ZERO®. Today, we offer healthcare institutions a solution to some of their biggest hidden problems – contamination leading to misdiagnosis of bloodstream infections, including sepsis, which can lead to unnecessary and prolonged antibiotic therapy, and false-positive CLABSIs. Tomorrow, we aspire to create a world free of in-vitro diagnostic errors where rapid, accurate test results improve the lives of patients and providers alike. We know that setting new standards of care is a journey enabled by purposeful innovation, partnerships, and perseverance. As the first step of our journey, we have successfully developed and proven our evidence-based technology platform, Steripath, which we’ve coupled with unparalleled support to change clinical practices and prevent unnecessary patient harm as well as system-wide costs associated with the misdiagnosis of sepsis. Our mission is further enabled by reducing false-positive CLABSIs and leveraging our extensive intellectual property portfolio – consisting of over 100 issued method, apparatus, and design patents and 70+ patent applications pending – to address other important sources of diagnostic error that are harmful to patients and costly to hospitals.

Novuson, a spinout from the University of Washington's highly regarded Applied Physics Laboratory's Center for Industrial and Medical Ultrasound, is developing its Direct Therapeutic Ultrasound (DTU) technology platform for coagulation and hemostatic control in surgical and trauma procedures.

At Opticyte, we are committed to transforming the standard of care for the leading causes of organ failure, including sepsis. The problem is massive, is expensive to treat, and leads to one death every 2.8 seconds globally. Current technologies fail to provide clinicians with the definitive data they need to diagnose, monitor, and treat patients in real-time, when they have the best chance of preventing organ failure. Unlike existing oximeters, our VitalO₂ is accurate for people of all skin tones. Our VitalO₂ monitor is the first and only single solution to provide definitive, continuous, and actionable insights for these critical unmet needs. The FDA awarded Opticyte Breakthrough Device Designation on the strength of our clinical data and the promise of our technology to save lives. Opticyte's executive and advisory team includes pioneers in new optical spectroscopy and multivariate analysis technology, leaders in medical device commercialization, and medical clinicians. The company's early funding successes, research validation, and product development milestones provide credibility and reinforce our position as a disruptive medical device innovator.

A device from OtoNexus Medical Technologies uses air-coupled ultrasound technology to accurately assess middle ear infections, and in particular to differentiate when and when not to prescribe antibiotics.

PATH is a global team of innovators working to accelerate health equity so all people and communities can thrive.

We realize product visions that enhance people's lives. Product Creation Studio is an integrated product development consultancy. We fuse our passion and expertise in strategic design and precision engineering to create, innovate, and solve complex challenges for our clients across the consumer, medical, and industrial fields. From burgeoning start-ups to top-tiered companies, we make products happen.

Remmie Health is a digital health technology venture that delivers next-generation, AI-enabled, ear-nose-throat care for easier, accessible diagnosis, timely intervention, and exceptional patient care. Remmie is a patient-centric, primary care telemedicine/at-home examination device + API + AI system that enables patients/consumers to receive virtual/hybrid care from healthcare professionals, covering 22+ most commonly occurring respiratory conditions, causing over 120 million annual visits as the leading reason for ambulatory care, impacting every family 2-9 times a year. The winner of the Muse Innovation Fellowship, UCLA Knapp Venture Competition, and Rice Business Plan Competition, Remmie Health is a UnitedHealthcare Accelerator (powered by Techstars) and Plug and Play portfolio company. The company is based in Seattle, WA.

Solius has worked for almost a decade to isolatebeneficial UVBspectrumlight and package it into a safe, effective, smart device. They work with leading experts in the world of phototherapy and vitamin D research to develop and improve the product.

Sound Decision for Imaging's mission is to provide an objective and practical QC program to ultrasound department managers and service providers in order to:1. optimize clinical performance,2. reduce the cost of operations, and3. provide the technical elements needed for department accreditationby employing a new scientific approach to Ultrasound Quality Control.

SoundHealth is on a mission to help the world breathe free. As a startup, we specialize in AI-based, personalized, drug-free treatment designed to improve respiratory health. SoundHealth is founded by an experienced team of serial entrepreneurs in the technology and medical fields. SoundHealth's inaugural product, SONU, is the world's first FDA-authorized wearable device offering drug-free, spray-free, personalized relief from nasal congestion.

The company is developing a ventricular shunt, for children with hydrocephalus.

Tasso is a fast-growing Seattle-based startup focused on delivering at-home diagnostic testing to those who need it most. We are growing our footprint with leading health systems, clinical research organizations, academic medical centers, and more who are looking to deliver clinical-grade, convenient diagnostic tests to their patients. Tasso was originally founded to find a better way to collect blood instead of a painful fingerstick or time-consuming venous draw. Since then, our products have been used in pharmaceutical clinical trials, by Olympians as part of a new virtual anti-doping program, and broadly by hospital systems across the US.

Technical Safety Services is a leading compliance, calibration and certification service provider for laboratories, hospitals, and pharmacies with locations across the United States. Our customers include leading life sciences and healthcare companies and renowned research institutions. Our Family of Companies includes Technical Safety Services (TSS), Evergreen Medical Services, and Cornerstone Commissioning. We are rapidly growing and looking for additional passionate and talented employees to join our team and partner with TSS' customers who are doing dramatic work focused on improving the human condition.

The Weinberg Group, a ProPharma Group company, is the global leader in regulatory and compliance services, with headquarters in Washington, D.C. For over 35 years, we have provided biotech, medical device, and pharmaceutical consulting services to companies of every size on every continent, supplying them with viable and efficient drug development pathways and compliance solutions. The Weinberg Group was acquired by ProPharma Group on January 25, 2019. By joining forces, we expand our current service portfolio of pre-approval/pre-clinical regulatory service solutions to also now include post-approval regulatory services, establishing an end-to-end global solution for our clients. Our service footprint now allows us to service clients at all stages of drug, device and biotechnology development, and in any geographic region.

Uptake Medical® developed innovative medical technologies for the treatment of lung diseases. Its first product, InterVapor®, was the first and only approach to endoscopic lung volume reduction for people with severe emphysema that uses the body's natural healing process without leaving any foreign materials in the lung. Uptake Medical was acquired in July 2016 by Uptake Medical Technology Inc, a subsidiary of Broncus Holding Corp.

Our purpose is to disrupt disease transmission. At Varro Life Sciences, we develop innovative products and technologies that make a global impact across economic and cultural borders. We are ambitious and dedicated in our pursuit to leverage technology that saves lives, ensures safe environments, and prevents future pandemics. The company was established in January 2020 as Y2X Life Sciences, and the company name was changed in October 2024.

Ventec Life Systems is a Washington-based medical device company that develops portable ventilation systems for patients with respiratory diseases.

Wavely Diagnostics builds phone-based tools to support pediatric care. Their first tool is a phone app that can detect fluid in the middle ear to help a doctor diagnose and treat ear infections remotely.